333 related articles for article (PubMed ID: 11045261)
21. The characteristics of peritoneal healing after catheter insertion in a rat model of peritoneal dialysis.
Wieczorowska-Tobis K; Polubinska A; Kuzlan-Pawlaczyk M; Pawlaczyk K; Breborowicz A; Oreopoulos DG
Adv Perit Dial; 1998; 14():36-9. PubMed ID: 10649687
[TBL] [Abstract][Full Text] [Related]
22. Amphotericin B, mercury chloride and peritoneal transport in rabbits.
Zweers MM; Douma CE; de Waart DR; Korevaar JC; Krediet RT; Struijk DG
Clin Nephrol; 2001 Jul; 56(1):60-8. PubMed ID: 11499660
[TBL] [Abstract][Full Text] [Related]
23. Immunopathological changes in a uraemic rat model for peritoneal dialysis.
Zareie M; De Vriese AS; Hekking LH; ter Wee PM; Schalkwijk CG; Driesprong BA; Schadee-Eestermans IL; Beelen RH; Lameire N; van den Born J
Nephrol Dial Transplant; 2005 Jul; 20(7):1350-61. PubMed ID: 15840671
[TBL] [Abstract][Full Text] [Related]
24. Peritoneal dialysis fluid-induced changes of the peritoneal membrane are reversible after peritoneal rest in rats.
Zareie M; Keuning ED; ter Wee PM; Beelen RH; van den Born J
Nephrol Dial Transplant; 2005 Jan; 20(1):189-93. PubMed ID: 15572385
[TBL] [Abstract][Full Text] [Related]
25. Intraperitoneal atrial natriuretic peptide increases peritoneal fluid and solute removal.
Wang T; Cheng HH; Heimbürger O; Chen C; Bergström J; Lindholm B
Kidney Int; 2001 Aug; 60(2):513-9. PubMed ID: 11473634
[TBL] [Abstract][Full Text] [Related]
26. The effect of oxidative stress inhibition with trimetazidine on the peritoneal alterations induced by hypertonic peritoneal dialysis solution.
Günal AI; Celiker H; Ustundag B; Akpolat N; Dogukan A; Akcicek F
J Nephrol; 2003; 16(2):225-30. PubMed ID: 12768069
[TBL] [Abstract][Full Text] [Related]
27. Long-term effects of glycylglycine peritoneal dialysis solution with neutral pH on peritoneum in rats.
Wieczorowska-Tobis K; Korybalska K; Polubińska A; Radkowski M; Breborowicz A; Montagne A; Oreopoulos DG
Adv Perit Dial; 1997; 13():42-6. PubMed ID: 9360649
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of an experimental rat model for peritoneal dialysis: fluid and solute transport characteristics.
Park MS; Heimbürger O; Bergström J; Waniewski J; Werynski A; Lindholm B
Nephrol Dial Transplant; 1994; 9(4):404-12. PubMed ID: 8084455
[TBL] [Abstract][Full Text] [Related]
29. Phospholipids in dialysate and the peritoneal surface layer.
Zhong JH; Guo QY; Ye RG; Lindholm B; Wang T
Adv Perit Dial; 2000; 16():36-41. PubMed ID: 11045258
[TBL] [Abstract][Full Text] [Related]
30. Hypertonicity of dialysis fluid suppresses intraperitoneal inflammation.
Wieczorowska-Tobis K; Styszynski A; Polubinska A; Radkowski M; Breborowicz A; Oreopoulos DG
Adv Perit Dial; 2000; 16():262-6. PubMed ID: 11045307
[TBL] [Abstract][Full Text] [Related]
31. Improvement of a chronic rat model for peritoneal dialysis by using heparin-coated catheters.
Zareie M; Keuning ED; ter Wee PM; Beelen RH; van den Born J
Adv Perit Dial; 2004; 20():150-4. PubMed ID: 15384817
[TBL] [Abstract][Full Text] [Related]
32. Preservation of peritoneal morphology and function by pentoxifylline in a rat model of peritoneal dialysis: molecular studies.
Hung KY; Huang JW; Chiang CK; Tsai TJ
Nephrol Dial Transplant; 2008 Dec; 23(12):3831-40. PubMed ID: 18614818
[TBL] [Abstract][Full Text] [Related]
33. Compare the effects of intravenous and intraperitoneal mesenchymal stem cell transplantation on ultrafiltration failure in a rat model of chronic peritoneal dialysis.
Baştuğ F; Gündüz Z; Tülpar S; Torun YA; Akgün H; Dörterler E; Düşünsel R; Poyrazoğlu H; Baştuğ O; Dursun İ
Ren Fail; 2014 Oct; 36(9):1428-35. PubMed ID: 25110139
[TBL] [Abstract][Full Text] [Related]
34. Comparison of peritoneal equilibration test with 2.27% and 3.86% glucose dialysis solution.
Cara M; Virga G; Mastrosimone S; Girotto A; Rossi V; D'Angelo A; Bonfante L
J Nephrol; 2005; 18(1):67-71. PubMed ID: 15772925
[TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetics and tissue distribution of intraperitoneal paclitaxel with different carrier solutions.
Mohamed F; Marchettini P; Stuart OA; Sugarbaker PH
Cancer Chemother Pharmacol; 2003 Nov; 52(5):405-10. PubMed ID: 12879282
[TBL] [Abstract][Full Text] [Related]
36. Effect of increased dialysate fill volume on peritoneal fluid and solute transport.
Wang T; Heimbürger O; Cheng H; Waniewski J; Bergström J; Lindholm B
Kidney Int; 1997 Oct; 52(4):1068-76. PubMed ID: 9328947
[TBL] [Abstract][Full Text] [Related]
37. [Comparision of several different peritoneal fibrosis rat models].
Zhuo L; Liu FY; Peng YM; Liu YH; Liu H; Zhou LH; Xu XQ; Jiang JH
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Apr; 30(2):162-6. PubMed ID: 15898425
[TBL] [Abstract][Full Text] [Related]
38. [Experimental study on effect of ligustrazine on peritoneal ultrafiltrative function in rats].
Yang X; Ye R; Yang Q
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2000 Sep; 20(9):682-4. PubMed ID: 11789175
[TBL] [Abstract][Full Text] [Related]
39. [Extended assessment of peritoneal transport kinetics of substances and water as an important element of integrated dialysis care].
Baczyński D; Antosiewicz S; Waniewski J; Marciniak M; Wańkowicz Z
Pol Merkur Lekarski; 2004 Aug; 17(98):110-3. PubMed ID: 15603317
[TBL] [Abstract][Full Text] [Related]
40. Peritoneal dialysis solutions disturb the balance of apoptosis and proliferation of peritoneal cells in chronic dialysis model.
Zheng Z; Ye R; Yu X; Bergström J; Lindholm B
Adv Perit Dial; 2001; 17():53-7. PubMed ID: 11510297
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
